Skip to main content

Cannabis Research Within International Frameworks

Written by Johnny Green on . Posted in Science.

cannabis plant

Cannabis research is a key component to future success for the emerging international cannabis industry. All meaningful cannabis research provides further insight into the cannabis plant and how humans can harness its properties to benefit the world.

Compared to other areas of agriculture and medical research, cannabis research often involves additional hurdles and limitations due to domestic and global cannabis prohibition policies. Unfortunately, such policies make cannabis research more complicated than it needs to be.

Thankfully, cannabis research has increased in recent decades, with more and more jurisdictions modernizing their cannabis policies. There is still a lot of room for improvement, to be sure, but at least things are trending in the right direction.

International cannabis research efforts were at the center of a recent panel discussion at the International Cannabis Business Conference in Berlin. The panel was titled ‘Bridging Disciplines’ and was moderated by Lukáš Hurt, CEO of Green Publishing. Mr. Hurt was joined by:

  • Andy Mannsfeld, MD, Managing Director of EUCannaJobs
  • Prof. Dr. Simone Graeff-Hönninger, Chair of Agronomy at the Institute of Crop Science at the University of Hohenheim
  • Prof. Dr. Tamara Lah Turnšek, Biochemist and Researcher at the National Institute of Biology in Ljubljana, Slovenia
  • TJ Martin, Vice President of Research and Development at Abstrax
  • Božidar Radišic, Project Manager and Founder of the Research Nature Institute

Drawing from hands-on experience in crop science, cannabinoid research, product development, medical practice, and international policy, the panelists discussed how to advance cannabis research within the boundaries of international conventions.

Topics covered during the panel presentation included sustainable cultivation practices, the biochemical complexity of the cannabis plant, translational research for consumer and medical use, and the role of education and public engagement. You can view the panel discussion at this link here.